Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Tezacaftor-d6

Tezacaftor-d6 (VX-661-d6) is deuterium labeled Tezacaftor. Tezacaftor (VX-661) is a F508del CFTR corrector. It helps CFTR protein reach the cell surface. However, Ivacaftor (VX-770, HY-13017), a CFTR potentiator, helps to prolong the opening time of cell surface CFTR protein channels. Tezacaftor combining with Ivacaftor, shows potent efficacy against cystic fibrosis and diseases with homozygous for the CFTR Phe508del mutation. Moreover, Elexacaftor (VX-445, HY-111772) is also a CFTR corrector. Elexacaftor-Tezacaftor-Ivacaftor aims at with cystic fibrosis (CF) with at least one Phe508del mutation, often avoids the indication for lung transplantation[1][2][3][4].

Product Specifications

CAS Number

1961280-94-3

Product Name Alternative

VX-661-d6

UNSPSC

12352005

Target

CFTR; Isotope-Labeled Compounds

Related Pathways

Membrane Transporter/Ion Channel; Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Smiles

FC1=C(NC(C2(CC2)C3=CC=C4OC(OC4=C3)(F)F)=O)C=C5C(N(C[C@H](CO)O)C(C(C([2H])([2H])[2H])(CO)C([2H])([2H])[2H])=C5)=C1

Molecular Formula

C26H21D6F3N2O6

Molecular Weight

526.53

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Treatment with VX-661 and Ivacaftor in a Phase 2 Study Resulted in Statistically Significant Improvements in Lung Function in People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation. April 18, 2013|[3]Taylor-Cousar JL, et al. Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del. N Engl J Med. 2017 Nov 23;377 (21) :2013-2023. |[4]Burgel PR, et al. Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease. Am J Respir Crit Care Med. 2021 Jul 1;204 (1) :64-73. |[5]Huang Y, et al. Elexacaftor/Tezacaftor/Ivacaftor Improved Clinical Outcomes in a Patient with N1303K-CFTR Based on In Vitro Experimental Evidence. Am J Respir Crit Care Med. 2021 Nov 15;204 (10) :1231-1235.

Shipping Conditions

Room temperature

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

PARS2 shRNA (h) Lentiviral Particles
sc-78924-V 200 µL

PARS2 shRNA (h) Lentiviral Particles

Sign In for Pricing
View Details
(Z)-12-Heptacosene
TRC-H635230-5MG 5 mg

(Z)-12-Heptacosene

Sign In for Pricing
View Details
Human MGAT4C Pre-designed siRNA Set B
SI009545B 1 Each

Human MGAT4C Pre-designed siRNA Set B

Sign In for Pricing
View Details
Chicken Carboxypeptidase A5 (CPA5) ELISA kit
GTR10380545 96 Well

Chicken Carboxypeptidase A5 (CPA5) ELISA kit

Sign In for Pricing
View Details
Pou3f3-set siRNA/shRNA/RNAi Lentivector (Mouse)
37262094 4x 500 ng

Pou3f3-set siRNA/shRNA/RNAi Lentivector (Mouse)

Sign In for Pricing
View Details
Rabbit IgG Isotype Control FITC Conjugated
MBS9471213 0.1 mL

Rabbit IgG Isotype Control FITC Conjugated

Sign In for Pricing
View Details